Incoming international students are required to submit immunization forms by their schools before arriving in America. In the form they can always see a checkbox before tuberculosis vaccine. Routine vaccination is now provided in all developing countries against measles, polio, diphtheria, tetanus, pertussis, and tuberculosis. The majority of international student insurance in the United States (aka 美国留学生 保险), J-1 insurance (aka j1 保险), and OPT insurance (aka opt保险) cover the cost of vaccination including HPV. (hence, it is not recommended to waive American university insurance (aka waive 美国大学保险))
By the dawn of the 19th century, tuberculosis—or consumption—had killed one in seven of all the people that had ever lived. Throughout much of the 1800s, consumptive patients sought “the cure” in sanatoriums, where it was believed that rest and a healthful climate could change the course of the disease.
Poor medical technology, lack of medical insurance in the United States (aka 美国医疗保险), and limited medicine supplies panicked the public. Bacille Calmette-Guérin (BCG) was invented to fight against tuberculosis (TB) disease. This vaccine is not widely used in the United States, but it is often given to infants and small children in other countries where TB is common.
In terms of medical insurance recommendation (aka 医疗保险推荐) by health service bureaucracy, the Chinese government has unveiled an action plan to reinforce the prevention and control of tuberculosis (TB) amid global efforts to end the epidemic. The plan, which covers the period from 2019 to 2022, specified responsibilities of government agencies including those in charge of medical treatment, education, medical insurance and science and technology, and encouraged concerted efforts from various parties in society.
Actions would be taken to target key groups and areas, curb the spread of drug-resistant TB, and improve the capabilities of disease control and research. The National Health Commission will sign liability agreements with provincial areas with morbidity rates exceeding 55 in 100,000 to better supervise the implementation of prevention and control measures, according to the plan. China has seen decreases in TB morbidity in recent years. It now aims to lower its rate of morbidity and mortality to under 55 in 100,000 and three in 100,000 respectively by 2022.